The Chief Medical Officer of MapLight Therapeutics, Dr. Foff, has executed a sale of company stock valued at $126,639. This transaction is part of Dr. Foff's financial management activities and was reported in accordance with regulatory requirements. Details regarding the specific number of shares sold and the timing of the transaction have not been disclosed. MapLight Therapeutics continues to focus on its research and development efforts in the therapeutic sector.
Related Articles
Don't miss out on breaking stories and in-depth articles.